Pancrelipase

Common brands: Creon, Pulmozyme, Acid Reducer, Vitamin D, Omeprazole/Sodium Bicarbonate

Top reporter: Abbvie Inc.

Proton Pump Inhibitor [EPC]Recombinant Human Deoxyribonuclease 1 [EPC]Osmotic Laxative [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
36,968
Total Reports
18,583
Serious Reports
3,709
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.03%)

Patient Demographics

Male
15,306
Female
19,485

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Pancrelipase.

# Reaction Reports % of Total
1 DIARRHOEA 3,498
9.9%
2 DEATH 1,900
5.4%
3 NAUSEA 1,778
5.0%
4 WEIGHT DECREASED 1,709
4.8%
5 FATIGUE 1,558
4.4%
6 ABDOMINAL PAIN 1,500
4.2%
7 VOMITING 1,398
3.9%
8 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1,301
3.7%
9 PAIN 1,234
3.5%
10 ABDOMINAL PAIN UPPER 1,211
3.4%
11 PANCREATIC CARCINOMA 1,160
3.3%
12 DYSPNOEA 1,150
3.2%
13 MALAISE 1,127
3.2%
14 OFF LABEL USE 1,092
3.1%
15 DRUG INEFFECTIVE 1,090
3.1%
16 PNEUMONIA 1,040
2.9%
17 ASTHENIA 993
2.8%
18 HOSPITALISATION 985
2.8%
19 HEADACHE 963
2.7%
20 CONSTIPATION 958
2.7%
21 COUGH 932
2.6%
22 ABDOMINAL DISTENSION 872
2.5%
23 FLATULENCE 835
2.4%
24 FALL 831
2.3%
25 DIZZINESS 811
2.3%
26 CYSTIC FIBROSIS 777
2.2%
27 PYREXIA 739
2.1%
28 DECREASED APPETITE 716
2.0%
29 PANCREATITIS 707
2.0%
30 INFECTION 627
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.